首页> 外文期刊>Post?py Higieny i Medycyny Do?wiadczalnej >DNA microarray-based gene expression profiling in diagnosis, assessing prognosis and predicting response to therapy in colorectal cancer
【24h】

DNA microarray-based gene expression profiling in diagnosis, assessing prognosis and predicting response to therapy in colorectal cancer

机译:基于DNA芯片的基因表达谱在大肠癌的诊断,评估预后和预测对治疗的反应中

获取原文
       

摘要

Colorectal cancer is the most common cancer of the gastrointestinal tract. It is considered as a biological model of a certain type of cancerogenesis process in which progression from an early to late stage adenoma and cancer is accompanied by distinct genetic alterations.Clinical and pathological parameters commonly used in clinical practice are often insufficient to determine groups of patients suitable for personalized treatment. Moreover, reliable molecular markers with high prognostic value have not yet been determined. Molecular studies using DNA-based microarrays have identified numerous genes involved in cell proliferation and differentiation during the process of cancerogenesis. Assessment of the genetic profile of colorectal cancer using the microarray technique might be a useful tool in determining the groups of patients with different clinical outcomes who would benefit from additional personalized treatment.The main objective of this study was to present the current state of knowledge on the practical application of gene profiling techniques using microarrays for determining diagnosis, prognosis and response to treatment in colorectal cancer.
机译:大肠癌是最常见的胃肠道癌。它被认为是某种癌症发生过程的生物学模型,其中从早期到晚期腺瘤和癌症的进展伴随着明显的遗传改变。临床实践中常用的临床和病理学参数通常不足以确定患者组适合个性化治疗。此外,尚未确定具有高预后价值的可靠分子标志物。使用基于DNA的微阵列进行的分子研究已经确定了许多在癌发生过程中参与细胞增殖和分化的基因。使用微阵列技术评估结直肠癌的遗传特征可能是确定具有不同临床结局的患者群体的有用工具,这些患者将从其他个性化治疗中受益。这项研究的主要目的是介绍有关基因芯片技术在微阵列中用于确定大肠癌的诊断,预后和治疗反应的实际应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号